Cargando…

BNT-162b1: Worsening of minimal change disease and nephrotic syndrome: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569049/ http://dx.doi.org/10.1007/s40278-021-04931-2

Ejemplares similares

BNT-162b1: Stevens-Johnson syndrome: case report
Publicado: (2021)

Tozinameran: Nephrotic syndrome and minimal change disease : case report
Publicado: (2022)

Tozinameran: Minimal change disease with nephrotic syndrome and acute kidney injury: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

Tozinameran: De novo minimal change disease (MCD) and nephrotic syndrome: case report
Publicado: (2022)

BNT-162b1/clobetasol: Pernio and lack of efficacy: case report
Publicado: (2022)

A Case of Nephrotic Syndrome With Minimal-Change Disease and Waldenstrom’s Macroglobulinemia
por: Grabe, Darren W., et al.
Publicado: (2013)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Yellow nail syndrome accompanied by minimal-change nephrotic syndrome: A case report
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

Cerebral infarction in patient with minimal change nephrotic syndrome
por: Babu, A., et al.
Publicado: (2013)

Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine()
por: Sosa-Hernández, Oscar, et al.
Publicado: (2022)

Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection: a case report
por: Haruki, Ayumi, et al.
Publicado: (2018)

Minimal Change Nephrotic Syndrome Relapse after 52 Years of Remission: A Case Report
por: Yamabe, Hideaki, et al.
Publicado: (2018)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review
por: Silva, Sandra, et al.
Publicado: (2007)

Giant cell myocarditis after first dose of BNT162b2 – a case report
por: Hirsch, Valentin G., et al.
Publicado: (2022)

Minimal Change Nephrotic Syndrome in a Child with Systemic Lupus Erythematosus
por: Deshpande, Pankaj V.
Publicado: (2023)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report
por: Nishizono, Ryuzoh, et al.
Publicado: (2020)

Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
por: Hartley, James Leon, et al.
Publicado: (2022)

Nephrotic syndrome of minimal change disease following exposure to mercury-containing skin-lightening cream
por: Zhang, Lin, et al.
Publicado: (2014)

Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
por: Altermanini, Mohammad, et al.
Publicado: (2023)

Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report
por: Shibata, Yuko, et al.
Publicado: (2020)

Pseudothrombus deposition accompanied with minimal change nephrotic syndrome and chronic kidney disease in a patient with Waldenström's macroglobulinemia: A case report
por: Mwamunyi, Mercy Julian, et al.
Publicado: (2019)

Reactive arthritis following COVID-19 vaccination with BNT162b2
por: Lebowitz, Emily, et al.
Publicado: (2022)

Multiple Venous and Pulmonary Artery Thrombosis as the Presenting Features of Spontaneously Reversible Nephrotic Syndrome after Exposure to SARS-CoV-2 Virus (Pfizer/BioNTech BNT162b2) Vaccination
por: Thammathiwat, Theerachai, et al.
Publicado: (2022)

Effusive–constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report
por: Viani, Giacomo Maria, et al.
Publicado: (2022)

Unilateral Pleural Effusion after Third Dose of BNT162b2 mRNA Vaccination: Case Report
por: Athanasiou, Nikolaos K., et al.
Publicado: (2023)

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report
por: Kim, Eun-Ju, et al.
Publicado: (2023)

Rifampicin-Associated Secondary Minimal Change Disease Presenting with Nephrotic Syndrome in a Pulmonary Tuberculosis Patient
por: Sathi, Satyanand, et al.
Publicado: (2021)

Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature
por: Hoxha, Ariela, et al.
Publicado: (2023)

Successfully Treated Femoral Artery Thrombosis in a Patient with Minimal Change Nephrotic Syndrome
por: Lee, Ji Kyoung, et al.
Publicado: (2013)

Case Report on Paediatric Nephrotic Syndrome
por: Prince, Shireen, et al.
Publicado: (2020)

Tozinameran: Nephrotic syndrome: case report
Publicado: (2022)

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
por: Gouda, Wesam, et al.
Publicado: (2022)

BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
por: Ghosh, A. K., et al.
Publicado: (2022)

Myopericarditis following both BNT162b2 and NVX-CoV2373
por: Ahmad, Saima, et al.
Publicado: (2022)

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report
por: Mücke, Victoria Therese, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vt11ed84aof0esf26guf0b8ghk